NSE and ProGRP Are Promising Markers for Diagnosis, Efficacy Evaluation, Follow‐Up Monitoring, and Prognosis of Small Cell Esophageal Carcinoma
Sign Up to like & getrecommendations! Published in 2025 at "Thoracic Cancer"
DOI: 10.1111/1759-7714.70026
Abstract: To investigate the clinical implications of serum carcinoembryonic antigen (CEA), neuron specific enolase (NSE), and pro‐gastrin‐releasing peptide (ProGRP) in small cell esophageal carcinoma (SCEC). read more here.
Keywords: cell esophageal; progrp; small cell; esophageal carcinoma ... See more keywords
Pro-gastrin-releasing peptide expression in Ewing sarcoma cells in vitro and in vivo demonstrates its availability as a valuable tumor marker.
Sign Up to like & getrecommendations! Published in 2025 at "Biomedical research"
DOI: 10.2220/biomedres.46.111
Abstract: Pro-gastrin-releasing peptide (ProGRP) is the precursor of gastrin-releasing peptide (GRP), a neuropeptide hormone with diverse biological activities. ProGRP is an established tumor marker for small cell lung carcinoma (SCLC). Recently, we reported the usefulness of… read more here.
Keywords: progrp; tumor; cell; tumor marker ... See more keywords
Diagnostic value of tumor markers CEA, CYFRA21-1, SCC, and proGRP in detecting lung cancer
Sign Up to like & getrecommendations! Published in 2024 at "Indian Journal of Cancer"
DOI: 10.4103/ijc.ijc_490_20
Abstract: A single tumor marker may not comprehensively detect the lung cancer. We aimed to evaluate the diagnostic and predictive value of the tumor markers panels in lung cancer. A total of 203 patients with newly… read more here.
Keywords: lung cancer; tumor markers; cancer; progrp ... See more keywords